Genomic Profiling of Pancreatic Cystic Tumors

Launched by SAMSUNG MEDICAL CENTER · Dec 23, 2023

Keywords

ClinConnect Summary

This clinical trial is looking into pancreatic cysts, which are fluid-filled sacs in the pancreas. Researchers want to understand if analyzing the genetic material from these cysts can help determine the risk of cancer and differentiate between two types of cysts: mucinous and serous. To do this, they will collect samples from patients, including blood and fluid from the cysts, and examine them for specific genetic changes and other markers. The main goal is to see if these genetic changes are linked to cancer, while secondary goals include identifying genetic differences that can help tell the two types of cysts apart.

To participate in this trial, patients must have pancreatic cysts and be scheduled for a procedure to collect samples, such as a cyst aspiration or surgery. They also need to provide written consent to join the study. It's important to note that individuals with severe infections, drug abuse issues, or serious mental health problems may not be eligible. This study is not yet recruiting participants, but it aims to gather important information that could improve how we diagnose and treat pancreatic cysts in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Pancreatic cyst patients undergoing cyst aspiration or biopsy or surgical resection
• • Patients who gave written informed consent
• Exclusion Criteria:
• • Anyone who has not signed a written consent form.
• • Patients deemed unsuitable for research (severe infection, drug abuse, severe mental illness, etc.)